Live Breaking News & Updates on Michel Morris

Stay updated with breaking news from Michel morris. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New Johns Hopkins study challenges benefits of intermittent fasting

Both time-restricted eating and regularly planned meals led to similar weight loss results in study, suggesting total calories may be more important than meal timing ....

United States , Johns Hopkins , Nisa Maruthur , Michel Morris , University Of Illinois Chicago , American College Of Physician Internal Medicine Meeting , Johns Hopkins University , Internal Medicine , American College , Illinois Chicago ,

Netflix stock rally builds as company wins cheers for password-sharing success

Netflix shares have outperformed the broader tech universe so far this year, and a pair of analysts sees ample room for them to extend their recent run. ....

United States , Reif Ehrlich , Guggenheim Michel Morris , Jessica Reif Ehrlich , Netflix Inc , Wall Street , Michel Morris , Latin America ,

Hopkins Med news update

Hopkins Med news update
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

United States , University Of Southern California , North Dakota , San Francisco , Gerard Mullin , Jahan Fahimi , Alexander Pantelyat , Megan Ranney , Michaele Newman , Michel Morris , Kim Polyniak , Patrick Smith , University Of California , Johns Hopkins Atypical Parkinsonism Center Curepsp , Johns Hopkins University School Of Medicine , Johns Hopkins Children Center , Curepsp Center , Brown University , Hopkins Medicine , Experimental Medicine , Johns Hopkins University School , Johns Hopkins Medicine , Katherine Hoops , Johns Hopkins Children , Southern California , Clinical Infectious ,

Research news tip sheet: Story ideas from Johns Hopkins Medicine

Chronic itch known clinically as chronic pruritus is characterized as an unrelenting and sometimes even debilitating sensation to itch, and often lowers the quality of life for those who suffer with it. Treating the condition has been difficult because there are few Food and Drug Administration-approved therapies. Now, a recent case study by Johns Hopkins Medicine researchers provides evidence that a promising option for patients with chronic itch may already be available: medical marijuana (cannabis).
A report on the team s findings was published April 9, 2021, in
Chronic itch can be an especially difficult condition to treat, with off-label therapeutics often utilized, says Shawn Kwatra, M.D., assistant professor of dermatology at the Johns Hopkins University School of Medicine. With the increased utilization of medical marijuana and our knowledge of the role of the endocannabinoid system [a complex cell-signaling system that regulates a variety of functions in t ....

Johns Hopkins University , United States , Christina Holmes , Alexander Perdomo Pantoja , Shawn Kwatra , Adam Sapirstein , Michel Morris , Timothy Witham , Marisol Martinez , Michael Rosen , Florida State University , Johns Hopkins University Applied Physics Laboratory , University Hospitals Of Cleveland , Johns Hopkins Neurosurgery Spinal Fusion Laboratory , Johns Hopkins University School Of Medicine , Johns Hopkins Itch Center , Johns Hopkins Armstrong Institute For Patient Safety , Sheree Monet Wisdom , Drug Administration Approved , Johns Hopkins Medicine , Johns Hopkins University School , African American , Johns Hopkins Armstrong Institute , Patient Safety , Johns Hopkins Hospital , Smart Agent ,